தேசிய நிறுவனம் க்கு மருந்து ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய நிறுவனம் க்கு மருந்து ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய நிறுவனம் க்கு மருந்து ஆராய்ச்சி Today - Breaking & Trending Today

COVID-19: Delta variant remains big threat to Nigeria, experts warn


COVID-19: Delta variant remains big threat to Nigeria, experts warn
The Punch
Public health experts have warned that the delta variant of COVID-19 first detected in India remains a big threat to Nigeria, noting that it could spark a surge of the viral infection that will be difficult to contain.
According to the experts, while the country is vulnerable to a new wave of COVID-19 infection due to low vaccination coverage, the delta variant is of more concern because existing vaccines have not been conclusively proven to be effective against the strain confirmed to be more virulent and more transmissible. ....

Abuja Federal Capital Territory , Taiwo Obembe , Martin Emeje , Tedros Adhanom Ghebreyesus , Research Scientist , Public Health Physician , National Institute For Pharmaceutical Research , Associated Press , World Health Organisation , Pharmaceutical Research Scientist , Yaba Mainland , Sunday Alamba , National Institute , Pharmaceutical Research , கூட்டாட்சியின் மூலதனம் பிரதேசம் , ஆராய்ச்சி விஞ்ஞானி , பொது ஆரோக்கியம் மருத்துவர் , தேசிய நிறுவனம் க்கு மருந்து ஆராய்ச்சி , தொடர்புடையது ப்ரெஸ் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , மருந்து ஆராய்ச்சி விஞ்ஞானி , தேசிய நிறுவனம் , மருந்து ஆராய்ச்சி ,

Charles Wambebe


Professor Charles Wambebe has worked at Ahmadu Bello University, Zaria and Georgetown University, Washington DC. He also worked with WHO and served as the Pioneer DG/CEO of the National Institute for Pharmaceutical Research and Development, Abuja. Recipient of TWAS Prizes in Medical Sciences and Building Scientific Institutions in Africa. Served as Consultant to the AUC, ADB, ECA, WHO, UNDP. Pioneer Pro-Chancellor and Chairman, Bingham University, Nigeria. Fellow of the Nigerian Academy of Science, African Academy of Sciences, The World Academy of Sciences (TWAS), among others. Pioneered the R&D of Niprisan, for the management of sickle cell disorder. Developed phytomedicines for treatment of malaria, fungal infection, peptic ulcer and HIV. Published over 150 articles in international journals. Currently Professor ExtraOrdinaire at Tshwane University of Technology, Pretoria and Consultant to WHO on Traditional Medicine. He is also Honorary Professor of Pharmacology , Bingham Uni ....

South Africa , United States , Georgetown University , District Of Columbia , Abuja Federal Capital Territory , Charles Wambebe , World Academy Of Sciences , National Institute For Pharmaceutical Research , Bingham University , Ahmadu Bello University , Nigerian Academy Of Science , Professor Extraordinaire At Tshwane University Of Technology , African Academy Of Sciences , Prizes In Medical Sciences , Professor Charles Wambebe , National Institute , Pharmaceutical Research , Medical Sciences , Building Scientific Institutions , Nigerian Academy , African Academy , World Academy , Professor Extraordinaire , Tshwane University , Honorary Professor , African Indigenous Medical Knowledge ,